| Christopher Owen Edwards, MD | |
|
1514 Jefferson Hwy, New Orleans, LA 70121-2429 | |
| (504) 842-3980 | |
| Not Available |
| Full Name | Christopher Owen Edwards |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 12 Years |
| Location | 1514 Jefferson Hwy, New Orleans, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033479878 | NPI | - | NPPES |
| MD.208015 | Other | LA | NEUROLOGY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | MD.208015 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ochsner Home Health Of New Orleans | Metairie, LA | Home health agency |
| Ochsner Clinic Foundation | New orleans, LA | Hospital |
| Slidell Memorial Hospital | Slidell, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ochsner Clinic Llc | 8224933619 | 2403 |
News Archive
The recent report by NHS Cancer Director Professor Mike Richards on the uptake in the NHS of new cancer drugs makes clear that many more people are getting access to effective cancer drugs evaluated by the National Institute for Clinical Excellence.
Cryptosporidium parvum, an insidious, one-celled, waterborne parasite that lodges in the intestines of infected people and animals and for which there is currently no effective treatment, is missing key structures normally found in similar parasites, say researchers supported by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health. The results of their genome sequencing project, could help scientists home in on new drug targets that may lead to therapies for the disease.
KineMed Inc. today announced the renewal of a non-exclusive research collaboration with Pfizer Inc. for the advancement of novel approaches in metabolic disease, in particular Type II diabetes.
Sigma-Aldrich Corporation announced today it has entered into a new gene editing partnership with the University of Michigan Medical School's Vector Core. Under the partnership, Sigma-Aldrich will provide the Vector Core with Sigma CRISPR technology, experimental design consultation, and dedicated gene editing bioinformaticians.
A drug that removes excess iron and toxins from the body after a brain bleed did not show significant improvement in recovery or neurological function at three months after intracerebral hemorrhage (stroke), but showed some benefits at six months, according to late breaking science presented at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.
› Verified 7 days ago
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
The recent report by NHS Cancer Director Professor Mike Richards on the uptake in the NHS of new cancer drugs makes clear that many more people are getting access to effective cancer drugs evaluated by the National Institute for Clinical Excellence.
Cryptosporidium parvum, an insidious, one-celled, waterborne parasite that lodges in the intestines of infected people and animals and for which there is currently no effective treatment, is missing key structures normally found in similar parasites, say researchers supported by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health. The results of their genome sequencing project, could help scientists home in on new drug targets that may lead to therapies for the disease.
KineMed Inc. today announced the renewal of a non-exclusive research collaboration with Pfizer Inc. for the advancement of novel approaches in metabolic disease, in particular Type II diabetes.
Sigma-Aldrich Corporation announced today it has entered into a new gene editing partnership with the University of Michigan Medical School's Vector Core. Under the partnership, Sigma-Aldrich will provide the Vector Core with Sigma CRISPR technology, experimental design consultation, and dedicated gene editing bioinformaticians.
A drug that removes excess iron and toxins from the body after a brain bleed did not show significant improvement in recovery or neurological function at three months after intracerebral hemorrhage (stroke), but showed some benefits at six months, according to late breaking science presented at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Owen Edwards, MD 1514 Jefferson Hwy, New Orleans, LA 70121-2429 Ph: (504) 842-4000 | Christopher Owen Edwards, MD 1514 Jefferson Hwy, New Orleans, LA 70121-2429 Ph: (504) 842-3980 |
News Archive
The recent report by NHS Cancer Director Professor Mike Richards on the uptake in the NHS of new cancer drugs makes clear that many more people are getting access to effective cancer drugs evaluated by the National Institute for Clinical Excellence.
Cryptosporidium parvum, an insidious, one-celled, waterborne parasite that lodges in the intestines of infected people and animals and for which there is currently no effective treatment, is missing key structures normally found in similar parasites, say researchers supported by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health. The results of their genome sequencing project, could help scientists home in on new drug targets that may lead to therapies for the disease.
KineMed Inc. today announced the renewal of a non-exclusive research collaboration with Pfizer Inc. for the advancement of novel approaches in metabolic disease, in particular Type II diabetes.
Sigma-Aldrich Corporation announced today it has entered into a new gene editing partnership with the University of Michigan Medical School's Vector Core. Under the partnership, Sigma-Aldrich will provide the Vector Core with Sigma CRISPR technology, experimental design consultation, and dedicated gene editing bioinformaticians.
A drug that removes excess iron and toxins from the body after a brain bleed did not show significant improvement in recovery or neurological function at three months after intracerebral hemorrhage (stroke), but showed some benefits at six months, according to late breaking science presented at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.
› Verified 7 days ago
Korak Sarkar, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2820 Napoleon Ave Ste 810, New Orleans, LA 70115 Phone: 504-894-2395 | |
Miriam Maite Sevilla Saez-benito, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1525 River Oaks Rd W, New Orleans, LA 70123 Phone: 504-818-1392 | |
Dr. Maurice David Gelder, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 5323 Coliseum Street, New Orleans, LA 70115 Phone: 504-899-4160 | |
Abdul Hafeez Khan, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 719 Elysian Fields Ave, New Orleans, LA 70117 Phone: 504-942-8101 Fax: 504-942-8242 | |
Dr. Lucido Luciano Ponce Mejia, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2020 Gravier St Fl 7, New Orleans, LA 70112 Phone: 504-568-6120 Fax: 504-568-6127 | |
Jennifer Velander, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1542 Tulane Avenue, 2nd Floor, New Orleans, LA 70112 Phone: 504-568-6004 | |
Dr. Joshua Sanderson, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1750 St. Charles Ave., Suite 609, New Orleans, LA 70130 Phone: 504-232-1087 |